RDNT
What one share of RadNet holds
Services – Medical Laboratories
We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services.
RadNet’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $29.52 |
|---|---|
| Profit | −$0.27 |
| Capex (buildings and equipment) | $3.09 |
| Free cash flow | $0.94 |
| Cash and investments | $9.23 |
| Debt | $16.94 |
| Book value | $13.94 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $18.96 | $0.15 | $1.27 | $0.69 | — | $1.12 |
| 2017 | $19.45 | $0.00 | $1.29 | $1.71 | — | $1.29 |
| 2018 | $20.03 | $0.66 | $1.48 | $0.92 | — | $2.60 |
| 2019 | $22.97 | $0.29 | $1.48 | $0.60 | — | $3.01 |
| 2020 | $21.06 | −$0.29 | $1.85 | $2.74 | — | $3.21 |
| 2021 | $24.62 | $0.46 | $2.58 | $0.22 | — | $4.27 |
| 2022 | $24.95 | $0.17 | $2.08 | $0.47 | — | $5.77 |
| 2023 | $25.00 | $0.05 | $2.73 | $0.68 | — | $9.28 |
| 2024 | $24.47 | $0.04 | $2.52 | $0.60 | — | $12.19 |
| 2025 | $27.13 | −$0.25 | $2.84 | $1.14 | — | $14.08 |